In light of our successful Gt Biopharma, Inc. (NASDAQ:GTBP) interview March 25, 2021, after which the stock has doubled in price, we have decided to continue with our pipeline of interviews and schedule a call with the CEO and COO of a […]
In light of our successful Gt Biopharma, Inc. (NASDAQ:GTBP) interview March 25, 2021, after which the stock has doubled in price, we have decided to continue with our pipeline of interviews and schedule a call with the CEO and COO of a […]